The latest from Isomab

News & Events

Announcements, scientific updates and where to find us next.

  • News

Isomab presents landmark safety data at ESC 2026, clearing the path for next-generation therapies to promote blood vessel growth in coronary artery disease

  • News

Isomab appoints Dr Philip Brainin as Chief Executive Officer

  • News

Isomab makes two key appointments; Dr Shi Yin Foo as Non-Executive Director and Dr Gary Burgess as CMO

  • News

Isomab Announces Strategic Collaboration with Catalent

  • News

Isomab Appoints Dr Anker Lundemose as a Non-Executive Director